Linfeng Wu

机构：Wannan Medical College, Harbin University, Harbin Engineering University, Sun Yat-sen University, Peking University, Chengdu University of Information Technology, Fudan University, Chengdu University of Technology, Wenzhou Hospital of Traditional Chinese Medicine, Energy Research Institute, Zhongshan Hospital, The Affiliated Yongchuan Hospital of Chongqing Medical University, Taizhou Central Hospital, South China Institute of Collaborative Innovation, Chongqing Medical University · ORCID：0000-0003-0036-0455

发表论文 193 篇 · 总被引 27148 次 · h-index 24

代表论文

• Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer (2025 · Journal of Experimental & Clinical Cancer Research · 被引 14)
• Hypoxia‐induced PGK1 expression promotes esophageal squamous cell carcinoma progression via stimulating MYH9‐mediated GSK3β/β‐catenin signalling (2025 · Clinical and Translational Medicine · 被引 5)
• 1848MO Phase II study of firmonertinib in patients with previously treated advanced/metastatic non-small cell lung cancer (mNSCLC) with EGFR exon 20 insertion (ex20ins) mutations (2025 · Annals of Oncology · 被引 4)
• Knowledge, and attitude, and decisional conflict regarding biologics among patients with inflammatory bowel disease: a cross-sectional study (2025 · Frontiers in Medicine · 被引 3)
• Heat Load Prediction of Building Rooms Using Only the Whole Building Data via Heat Allocation Approach (2025 · Journal of Thermal Science · 被引 3)
• B4GALT1 deficiency attenuates steatohepatitis by regulating the PPARγ/ACSL4 axis (2026 · Hepatology Communications · 被引 2)